lifetech (Turkcell Group)

lifetech (Turkcell Group)

http://lifetech.by
https://www.linkedin.com/company/lifetech.by/

lifetech, also known as Turkcell Group, is a Privately Owned company headquartered in Belarus. Founded in 2012, it operates as a subsidiary of Turkcell Group (Holding) and employs approximately 140 individuals. Functioning as a software and development agency, the company specializes in information technology and services.

Revenue

Founded

2012

Headcount

136

Headquarters

Belarus

Primary Segment

Information Technology & Services

Ownership

Privately Owned

News Summary:

N/A

Subscribe for full access to lifetech (Turkcell Group)'s products in full detail

Subscribe for full access to lifetech (Turkcell Group)'s revenue in full detail

Jan

29th

2026

18:40

Emerging Tech, B2B Tag

LifeTech Warranty

LifeTech Warranty

Harris Door and Millwork

Nov

25th

2025

18:30

Simultaneous Repair of Iatrogenic Left Atrial and Aortic Perforations Using Ductus Arteriosus Occluders: A Case Report

ABSTRACT Iatrogenic perforation of the left atrium and aorta during transseptal puncture (TSP) is a rare but potentially life-threatening complication. This report presents the case of an elderly male patient with a 20-year history of atrial fibrillation who experienced this complication during a scheduled left atrial appendage closure procedure.

Wiley Online Library

Sep

23rd

2025

18:58

CT_Monitor Company

IT Supporting Teaching at LifeTech ITS Academy in Trieste

LifeTech ITS Academy in Trieste has recently stood out at the national level for implementing a modern desktop and graphics-workstation virtualization infrastructure, designed to radically innovate the approach to technical and scientific education. The project - developed by Spring Firm S.r.l., in collaboration with H3C for part of the hardware supply - marks a turning point for post-secondary training, making the learning experience more accessible, efficient, and flexible.

Sep

9th

2025

18:30

Regulatory and Legal

Minister visits ELPEN biomedical research facilities

Development Minister Takis Theodorikakos on Tuesday visited the three production facilities of the Greek pharmaceutical company ELPEN in Pikermi, as well as a new flagship biomedical technology research and innovation center, the Athens LifeTech Park, in Spata. These have been classified as a strategic investment, supported by the Ministry of Development with 14 million euros in subsidies and tax incentives, creating 1,600 new quality jobs.

Sep

6th

2025

17:46

China Top Protein & Antibody Manufacturer Insights from the 2025 PEGS Boston Summit

Alpha Lifetech Inc. Alpha Lifetech Inc. + +1 609-736-0910 info@alpha-lifetech.com Visit us on social media: LinkedIn Facebook YouTube X Legal Disclaimer: EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article.

Sep

1st

2025

01:00

Financial Results, CT_Monitor Company

LifeTech Scientific Corporation Announces 2025 Interim Results: Core Business Demonstrated Resilience, Domestic and Overseas Sales Both Increased

HONG KONG, Aug. 29, 2025 /PRNewswire/ -- LifeTech Scientific Corporation ("LifeTech" or the "Company", together with its subsidiaries, the "Group", stock code: 1302.HK), a medical device company specializing in minimally invasive interventional solutions for cardio-cerebrovascular and peripheral vascular diseases, today announced its unaudited consolidated results for the six months ended 30 June 2025 (the "Reporting Period").

Aug

29th

2025

17:21

Financial Results, CT_Monitor Company

Related Quotes LifeTech Scientific Corporation Announces 2025 Interim Results: Core Business Demonstrated Resilience, Domestic and Overseas Sales Both Increased

HONG KONG, Aug. 29, 2025 /PRNewswire/ -- LifeTech Scientific Corporation ("LifeTech" or the "Company", together with its subsidiaries, the "Group", stock code: 1302.HK), a medical device company specializing in minimally invasive interventional solutions for cardio-cerebrovascular and peripheral vascular diseases, today announced its unaudited consolidated results for the six months ended 30 June 2025 (the "Reporting Period").

Aug

28th

2025

18:30

Financial Results, CT_Monitor Company

LifeTech Scientific Corporation Announces 2025 Interim Results: Core Business Demonstrated Resilience, Domestic and Overseas Sales Both Increased

HONG KONG, Aug. 30, 2025 /PRNewswire/ -- LifeTech Scientific Corporation ("LifeTech" or the "Company", together with its subsidiaries, the "Group", stock code: 130...

Kalkine Media Canada

Aug

28th

2025

18:30

Financial Results, CT_Monitor Company

LifeTech Scientific Reports Resilience and Growth Strategies

LifeTech Scientific Corporation Interim Results Overview LifeTech Scientific Corporation, also known as LifeTech, a recognized player in the medical device industry, announced its interim results that reflect resilience amidst evolving market dynamics. With a focus on minimally invasive interventional solutions for various cardiovascular conditions, LifeTech reported substantial growth in revenue and a solid financial foundation.

Investors Hangout

Aug

21st

2025

18:39

Regulatory and Legal, CT_Monitor Company

LifeTech’s Innovative Heart Device Gains Regulatory Approval

LifeTech Scientific Corporation ( (HK:1302) ) has shared an update. LifeTech Scientific Corporation has announced that its Congenital Heart Defect Occluder has been admitted into the National Medical Products Administration’s Special Examination and Approval Procedure for Innovative Medical Devices.

Jul

21st

2025

13:55

Partnerships and Alliances, CT_Monitor Company

CorestemChemon Expands Global CRO Reach with ATG Lifetech, Targeting Next-Gen Preclinical Services

Strategic partnership to deliver transcriptomics-powered, organoid-based preclinical testing for high-impact drug discovery SEOUL, South Korea, July 20, 2025 /PRNewswire/ — CorestemChemon, a leading GLP-certified preclinical CRO based in South Korea, has entered into a strategic partnership with ATG Lifetech, a biotechnology company specializing in transcriptome analytics and organoid-based modeling.

Jul

21st

2025

08:53

Partnerships and Alliances, CT_Monitor Company

CorestemChemon Goes Global With ATG Lifetech CRO Alliance

SEOUL, South Korea , July 21, 2025 /PRNewswire/ -- CorestemChemon, a leading GLP-certified preclinical CRO based in South Korea , has entered into a strategic partnership with ATG Lifetech, a biotechnology company specializing in transcriptome analytics and organoid-based modeling.

Vietnam Investment Review

Analyst insight reports

A fast guide to FAST

The trouble with live sports

How digital signage, retail media and programmatic are fueling the DOOH growth

Sports content and distribution in 2026 and beyond

Subscribe to access all analyst insight reports